About Goldline Pharmaceutical
Goldline Pharmaceuticals has engaged itself in marketing pharmaceutical products branded as 'Goldline'. The product line of Goldline can be categorized into five groups: Goldline Pharma: It includes a range of 42 products for specialties including Physicians, Orthopedics, ENT, Chest Physicians, General and Specialty Surgery, Gastroenterology, Neurology, and Urology. Goldline Cardinal: It consists of a range of 54 products for the Specialty division in medical fields such as Physicians, Diabetologists, Endocrinologists, Cardiologists, and General Physicians. Goldline Aayushman: It consists of a range of 18 products for the Specialty division in medical fields such as Pediatricians, Child Specialists, Neonatologists, and General Practitioners. Goldline InLife: It includes a range of 22 products for the Specialty division in medical fields such as Intensivists, Critical Care Consultants, Super Specialty Surgeons, and Physicians. Goldline Wellness: It consists of a range of 10 products for Supportive care for patients undergoing chemotherapy for their illness. As the company does not manufacture any products, it collaborates with third parties which manufacture medicines according to market analysis and product specifications of the company. The firm does not produce any products but rather works with third-party producers who manufacture their products as per the firm's market research and product descriptions, thus ensuring quality and regulatory compliance.Their products are all marketed and sold using the Goldline brand name by our distribution partners who distribute the products to retailers and wholesalers. Currently, the firm uses 15 producers and 7 distribution firms for selling its products, and it also helps hospitals and healthcare institutions in procurement and supplies. The firm sells products in the states of Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan, and Bihar.
Checklist Quality Analysis
Live IPOs
National Stock Exchange of India
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
National Stock Exchange of India Mainboard | 17th Sep 2026 - 21st Sep 2026 | 22561.57 Cr | 8 Shares | ₹ 1700.00 | |
Antala Industries SME | 29th Oct 2026 - 5th Nov 2026 | 22.98 Cr | 2000 Shares | ₹ 62.00 |
